Form 4: ClearPoint Neuro CEO Joseph Burnett Reports Stock Transaction

Sentiment:

SEC Form 4 Filing


CEO Joseph Burnett of ClearPoint Neuro, Inc. reports disposition of shares to cover tax obligations related to vesting restricted stock.

Summary

  • On August 20, 2024, Joseph Michael Burnett, CEO and President of ClearPoint Neuro, Inc., disposed of 3,236 shares of common stock to cover tax withholding obligations.
  • The transaction was executed at a price of $11.26 per share.
  • Following the transaction, Burnett directly owns 249,625 shares of ClearPoint Neuro, Inc.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock transactions for tax obligations, indicating a neutral sentiment.

Stakeholder Impact

  • The transaction may have a minor impact on shareholders due to the change in insider ownership.

Key Dates

DateDescription
08/20/2024Date of stock transaction (disposal of shares).
08/21/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.